An Other News To Note news brief in the March 4, 2005, issue of BioWorld Today should have said SuperGen Inc. dosed the first patient in a Phase II trial of Orathecin capsules plus gemcitabine in pancreatic cancer.

Editor's Note: The correction has been made in BioWorld Online.